Emerging Infectious Disease is the infectious disease that is newly emerged from humans or the variants of a known pathogen (including the development of drug resistance or pathogenicity). With the globalization of transportation, the spreading of Emerging Infectious Diseases has become more rapid, and the impact has become more considerable than ever, especially with most of the Emerging Infectious Diseases being zoonosis. Zinexts Life Science is committed to providing the platforms and reagents for detecting infectious diseases; in addition to human medicine, we will also be expanding our technologies to live-stock veterinary medicine.
Our two major technology platforms are Real-time PCR and Isothermal Amplification based, the two technologies widely used in the clinical and veterinary fields. Real-time PCR provides quantitative and qualitative detection capabilities with both sensitivity and specificity. In addition to the Isothermal Amplification, other than the excellent qualitative efficiency, it has a more simple mechanical structure that is easier to carry and relocate.
Our two major technology platforms are Real-time PCR and Isothermal Amplification based, the two technologies widely used in the clinical and veterinary fields. Real-time PCR provides quantitative and qualitative detection capabilities with both sensitivity and specificity. In addition to the Isothermal Amplification, other than the excellent qualitative efficiency, it has a more simple mechanical structure that is easier to carry and relocate.
